Cytokinetics (CYTK) Change in Account Payables (2016 - 2024)
Historic Change in Account Payables for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $5.9 million.
- Cytokinetics' Change in Account Payables fell 2342.11% to $5.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$4.5 million, marking a year-over-year decrease of 2871.09%. This contributed to the annual value of -$4.5 million for FY2024, which is 2871.09% down from last year.
- Per Cytokinetics' latest filing, its Change in Account Payables stood at $5.9 million for Q4 2024, which was down 2342.11% from $1.7 million recorded in Q3 2024.
- In the past 5 years, Cytokinetics' Change in Account Payables ranged from a high of $13.0 million in Q4 2022 and a low of -$10.3 million during Q1 2024
- Moreover, its 5-year median value for Change in Account Payables was $406500.0 (2021), whereas its average is -$124850.0.
- Examining YoY changes over the last 5 years, Cytokinetics' Change in Account Payables showed a top increase of 90710.9% in 2022 and a maximum decrease of 63089.38% in 2022.
- Cytokinetics' Change in Account Payables (Quarter) stood at $1.3 million in 2020, then soared by 193.98% to $3.9 million in 2021, then skyrocketed by 238.29% to $13.0 million in 2022, then plummeted by 40.9% to $7.7 million in 2023, then dropped by 23.42% to $5.9 million in 2024.
- Its Change in Account Payables stands at $5.9 million for Q4 2024, versus $1.7 million for Q3 2024 and -$1.8 million for Q2 2024.